Pancreatic Cancer Research

ResearcherUniversity of Nebraska Medical CenterNo recent work listed

Siyuan Tang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0501-8504; OpenAlex author ID A5017958030. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2021: 2 papers · 2022: 1 paper · 2023: 1 paper

Papers 4

  1. Uncovering Tumor-Promoting Roles of Activin A in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/advs.202207010↗
  2. Polymeric Chloroquine as an Effective Antimigration Agent in the Treatment of Pancreatic Cancer. Co-author DOI 10.1021/acs.molpharmaceut.2c00596↗
  3. Polycation fluorination improves intraperitoneal siRNA delivery in metastatic pancreatic cancer. First author DOI 10.1016/j.jconrel.2021.03.028↗
  4. Intraperitoneal siRNA Nanoparticles for Augmentation of Gemcitabine Efficacy in the Treatment of Pancreatic Cancer. Co-author DOI 10.1021/acs.molpharmaceut.1c00653↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. David Oupický · 4 shared papers, 2021–2023 · strength 0.60
  2. Ling Ding · 2 shared papers, 2021–2022 · strength 0.30
  3. Ying Xie · 2 shared papers, 2021 · strength 0.25
  4. Hang Yu · 2 shared papers, 2021 · strength 0.25
  5. Thomas C. Caffrey · 1 shared paper, 2023 · strength 0.18
  6. Seok‐Yeong Yu · 1 shared paper, 2023 · strength 0.18
  7. So‐Youn Kim · 1 shared paper, 2023 · strength 0.18
  8. Michael Anthony Hollingsworth · 1 shared paper, 2023 · strength 0.18
  9. Sudipta Panja · 1 shared paper, 2022 · strength 0.16
  10. Rubayat Islam Khan · 1 shared paper, 2022 · strength 0.16
  11. David Větvička · 1 shared paper, 2021 · strength 0.12
  12. Rakesh K. Singh · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.